$1.03
-0.025-2.36%
가까이에: Nov 20, 4:00 PM EST
$1.01
-0.025-2.42%
시간외: 4:37 PM EST
The average analyst price target for Dogwood Therapeutics is $12, 1088.1% above the current price. The one analyst covering it rates it Buy. The latest change came on Sep 30, 2025, when HC Wainwright & Co. raised its price target on Dogwood Therapeutics from $10 to $12 and kept a Buy rating.
Price Target Range — 4 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
